Humanigen Inc (HGENQ)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Humanigen Revenue (Quarterly): 0.221M for March 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 0.221M |
| December 31, 2022 | 0.221M |
| September 30, 2022 | 0.221M |
| June 30, 2022 | 1.036M |
| March 31, 2022 | 1.036M |
| December 31, 2021 | 1.037M |
| September 30, 2021 | 1.036M |
| June 30, 2021 | 1.036M |
| March 31, 2021 | 0.486M |
| December 31, 2020 | 0.312M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 |
| Date | Value |
|---|---|
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 0.004M |
| September 30, 2013 | 0.009M |
| June 30, 2013 | 0.015M |
| March 31, 2013 | 0.016M |
| December 31, 2012 | 0.018M |
| September 30, 2012 | 0.069M |
| June 30, 2012 | 2.992M |
| March 31, 2012 | 3.018M |
| December 31, 2011 | 5.869M |
| September 30, 2011 | 5.804M |
| June 30, 2011 | 4.263M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.221M
Minimum
Sep 2022
1.037M
Maximum
Dec 2021
0.6642M
Average
0.761M
Median
Revenue (Quarterly) Benchmarks
| Item 9 Labs Corp | 5.022M |
| Green Hygienics Holdings Inc | 0.0631M |
| Cantabio Pharmaceuticals Inc | -- |
| Affymax Inc | -- |
| Statera BioPharma Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.182M |
| Total Expenses (Quarterly) | 4.456M |
| EPS Diluted (Quarterly) | -0.04 |
| Profit Margin (Quarterly) | -1.89K% |